Alec Marantz
#50,189
Most Influential Person Now
American linguist
Alec Marantz's AcademicInfluence.com Rankings
Alec Marantzcommunications Degrees
Communications
#1538
World Rank
#2293
Historical Rank
#736
USA Rank
Grammar
#8
World Rank
#13
Historical Rank
#2
USA Rank
Linguistics
#494
World Rank
#649
Historical Rank
#189
USA Rank
Download Badge
Communications
Why Is Alec Marantz Influential?
(Suggest an Edit or Addition)According to Wikipedia, Alec Marantz is an American linguist and researcher in the fields of syntax, morphology, and neurolinguistics. Until 2007, he was Kenan Sahin Distinguished Professor of Linguistics at Massachusetts Institute of Technology, and Research Director of KIT/MIT MEG Joint Research Lab. Since 2007, he has been Professor of Linguistics and Psychology at New York University.
Alec Marantz's Published Works
Published Works
- Prevention of adriamycin-induced cardiotoxicity by prenylamine: a pilot double blind study. (1987) (24)
- A controlled trial of the effect of 4-hydroxypyrazolopyrimidine (allopurinol) on the toxicity of a single bolus dose of 5-fluorouracil. (1985) (23)
- Phase II study of gemcitabine, 5-fluorouracil, and leucovorin in patients with pancreatic cancer. (2001) (18)
- The Role of Prenylamine in the Prevention of Adriamycin-Induced Cardiotoxicity. A Review of Experimental and Clinical Findings (1988) (17)
- The cyclophosphamide, hexamethylmelamine, 5 fluorouracil (CHF) regimen in the treatment of advanced and recurrent ovarian cancer. (1985) (15)
- Neoadjuvant chemotherapy with cisplatin, ifosfamide and 5-fluorouracil in the treatment of locally advanced cervical cancer. (2000) (12)
- Prognosis of metastatic giant cell tumor of bone in the pre-denosumab era. A systematic review and a meta-analysis (2018) (12)
- Phase II trial of gemcitabine (GEM), 5-Fluoruracil (5-FU) and leucovorin (LV) in advanced pancreatic cancer (PC) (1999) (10)
- Sequential methotrexate, 5-fluorouracil (high-dose), and doxorubicin for advanced gastric cancer. (1986) (9)
- Prenylamine inhibition of adriamycin-induced cardiomyopathy in mice. (1982) (7)
- PEGYLATED LIPOSOMAL DOXORUBICIN IN AIDS-RELATED KAPOSI'S SARCOMA (1998) (6)
- 5 fluorouracil cyclophosphamide and mitoxantrone fucimix vs fucimix prednisone pdn for advanced breast cancer abc a prospective and randomized trial preliminary report (1989) (1)
- Methotrexate plus 4 epiadriamycin ftorafur in the treatment of advanced gastric and pancreatic cancer phase ii (1986) (0)
- 358 Navelbine (NVB) plus mitomycin (MMC) or mitoxantrone (MTZ): A randomized trial in anthracycline breast cancer resistant (ABCR) patients. Preliminary report (1995) (0)
- Retrospective analysis of the use of paclitaxel in HIV patients with Kaposi Sarcoma (KS): Institutional experience. (2015) (0)
- Cancer of Unknown Primary Site (2010) (0)
- FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health Organization. (1987) (0)
- [The dilemma of cancer therapy and the oncologist-patient relationship]. (1998) (0)
- Hyperglycemia as a prognostic factor in cancer. (2013) (0)
This paper list is powered by the following services:
Other Resources About Alec Marantz
What Schools Are Affiliated With Alec Marantz?
Alec Marantz is affiliated with the following schools: